 Albert Kim
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 8 | 2024 | 979 | 1.720 |
Why?
| | Semantics | 3 | 2012 | 89 | 1.100 |
Why?
| | Comprehension | 3 | 2023 | 156 | 1.040 |
Why?
| | Evoked Potentials | 2 | 2017 | 108 | 0.900 |
Why?
| | Psycholinguistics | 2 | 2023 | 19 | 0.800 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2024 | 663 | 0.780 |
Why?
| | Evoked Potentials, Visual | 2 | 2012 | 30 | 0.780 |
Why?
| | Vocabulary | 2 | 2012 | 41 | 0.770 |
Why?
| | Pattern Recognition, Visual | 2 | 2012 | 86 | 0.740 |
Why?
| | Meningeal Neoplasms | 4 | 2023 | 87 | 0.730 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 636 | 0.680 |
Why?
| | Precision Medicine | 1 | 2023 | 337 | 0.680 |
Why?
| | Brain Mapping | 3 | 2012 | 524 | 0.670 |
Why?
| | Brain | 5 | 2023 | 2371 | 0.640 |
Why?
| | Reading | 2 | 2017 | 149 | 0.620 |
Why?
| | Aptitude | 1 | 2017 | 38 | 0.560 |
Why?
| | Individuality | 1 | 2017 | 146 | 0.530 |
Why?
| | Encephalitis | 1 | 2018 | 127 | 0.530 |
Why?
| | Dementia | 1 | 2018 | 187 | 0.490 |
Why?
| | Memory, Short-Term | 1 | 2017 | 225 | 0.490 |
Why?
| | Cerebral Cortex | 1 | 2017 | 380 | 0.460 |
Why?
| | Disease Progression | 2 | 2022 | 2380 | 0.400 |
Why?
| | Meningeal Carcinomatosis | 2 | 2021 | 8 | 0.390 |
Why?
| | Meningioma | 2 | 2023 | 77 | 0.380 |
Why?
| | Electroencephalography | 4 | 2017 | 362 | 0.380 |
Why?
| | Antineoplastic Agents, Immunological | 2 | 2024 | 152 | 0.370 |
Why?
| | Autoantibodies | 1 | 2018 | 1346 | 0.350 |
Why?
| | Speech Perception | 1 | 2011 | 79 | 0.340 |
Why?
| | Melanoma | 2 | 2023 | 620 | 0.270 |
Why?
| | Ipilimumab | 2 | 2021 | 27 | 0.240 |
Why?
| | Tumor Microenvironment | 3 | 2022 | 430 | 0.240 |
Why?
| | Immunotherapy | 4 | 2023 | 474 | 0.230 |
Why?
| | Neovascularization, Pathologic | 1 | 2024 | 281 | 0.200 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 76 | 0.190 |
Why?
| | Photic Stimulation | 2 | 2012 | 203 | 0.180 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2021 | 37 | 0.180 |
Why?
| | Glioblastoma | 1 | 2023 | 253 | 0.180 |
Why?
| | Subthalamic Nucleus | 1 | 2020 | 39 | 0.170 |
Why?
| | Humans | 18 | 2024 | 114698 | 0.170 |
Why?
| | Reaction Time | 2 | 2012 | 376 | 0.170 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2021 | 194 | 0.170 |
Why?
| | Glioma | 1 | 2023 | 294 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 4 | 2024 | 3053 | 0.170 |
Why?
| | Deep Brain Stimulation | 1 | 2020 | 72 | 0.170 |
Why?
| | ELAV Proteins | 1 | 2018 | 12 | 0.150 |
Why?
| | Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2018 | 14 | 0.150 |
Why?
| | Male | 8 | 2024 | 55606 | 0.140 |
Why?
| | Aged | 5 | 2024 | 19074 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 1355 | 0.140 |
Why?
| | Prognosis | 1 | 2024 | 3329 | 0.130 |
Why?
| | Parkinson Disease | 1 | 2020 | 345 | 0.130 |
Why?
| | Adult | 5 | 2024 | 30553 | 0.130 |
Why?
| | Follow-Up Studies | 1 | 2024 | 4411 | 0.120 |
Why?
| | Cerebral Hemorrhage | 1 | 2015 | 96 | 0.120 |
Why?
| | Young Adult | 3 | 2017 | 10471 | 0.120 |
Why?
| | Female | 7 | 2024 | 59520 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2015 | 221 | 0.110 |
Why?
| | Functional Laterality | 1 | 2012 | 198 | 0.090 |
Why?
| | Universities | 1 | 2012 | 340 | 0.080 |
Why?
| | Middle Aged | 3 | 2024 | 26738 | 0.080 |
Why?
| | Survival Analysis | 2 | 2021 | 1211 | 0.080 |
Why?
| | Students | 1 | 2012 | 502 | 0.070 |
Why?
| | Adolescent | 2 | 2017 | 17853 | 0.070 |
Why?
| | Aging | 1 | 2015 | 1618 | 0.060 |
Why?
| | Anorexia | 1 | 2021 | 18 | 0.050 |
Why?
| | Models, Psychological | 1 | 2023 | 297 | 0.050 |
Why?
| | Hepatitis | 1 | 2021 | 45 | 0.050 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 26 | 0.050 |
Why?
| | Nausea | 1 | 2021 | 101 | 0.050 |
Why?
| | Time Factors | 1 | 2011 | 6116 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2021 | 33 | 0.050 |
Why?
| | Language | 1 | 2023 | 263 | 0.050 |
Why?
| | Exanthema | 1 | 2021 | 74 | 0.050 |
Why?
| | Globus Pallidus | 1 | 2020 | 17 | 0.050 |
Why?
| | Fever | 1 | 2021 | 280 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 188 | 0.040 |
Why?
| | Fatigue | 1 | 2021 | 294 | 0.040 |
Why?
| | Executive Function | 1 | 2023 | 380 | 0.040 |
Why?
| | Colitis | 1 | 2021 | 223 | 0.040 |
Why?
| | Piperazines | 1 | 2021 | 309 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2021 | 719 | 0.040 |
Why?
| | Pyridines | 1 | 2021 | 425 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 687 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 989 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1141 | 0.030 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2015 | 9 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2015 | 80 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 259 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 512 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2015 | 927 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2313 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 4410 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6347 | 0.010 |
Why?
|
|
Kim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|